搜索并找到您需要的 CMO / CDMO
为您的药物开发和制造项目寻找高技能合作伙伴。
市场: EMA (EU), NMPA (China), Health Canada (Canada), ANVISA (Brazil), COFEPRIS (Mexico), 俄罗斯卫生当局, MHRA (UK), SFDA (Saudi Arabia), Turkish Health Authorities, TGA (Australia)
遵守: ISO, Roszdravnadzor (Russia GMP), ECOVADIS, TGA (Australia GMP), UAE Ministry of Health & Prevention, NMPA (China GMP), EMA (EU GMP), Health Canada (Canada GMP), ANVISA (Brazil)
使用: 人类
批量大小: 大的, 小的, 中等的
服务: 分析/质量控制服务, 包装, 质量保证服务, 制造服务
OEB(职业暴露带): 3(PDE = 100 - 1,000 微克/天), 1 / 低危害(PDE > 10,000 µg/天), 2(PDE = 1,000 - 10,000 微克/天)
受控物质: 滥用和医疗用途的可能性很高
类别/产品: FDF / 药品, 服务
地区: 欧洲

SENN Chemicals | R&D and Kilo Lab | Dielsdorf, Switzerland
Senn Chemicals
瑞士肽和肽中间体研发基地,拥有 SPPS、LPPS、混合合成、公斤级实验室放大、纯化和分析。
服务: 后勤, 开发服务, 制造服务, 分析/质量控制服务, 质量保证服务, 监管服务, 包装
地区: 欧洲
类别/产品: 化妆品, 化学合成, 服务, 粒子工程
批量大小: 小的

SENN Chemicals | Small Scale GMP Lab | Dielsdorf, Switzerland
Senn Chemicals
小型 GMP 肽和有机合成实验室,适用于需要灵活 cGMP 生产的临床、利基和高价值项目。
服务: 后勤, 开发服务, 制造服务, 分析/质量控制服务, 质量保证服务, 监管服务, 包装
地区: 欧洲
类别/产品: 化学合成, 粒子工程
批量大小: 小的

SENN Chemicals | GMP Production | Dielsdorf, Switzerland
Senn Chemicals
瑞士 cGMP 生产基地,用于从试点到早期商业规模的 LPPS、SPPS 和混合肽生产。
服务: 后勤, 开发服务, 制造服务, 分析/质量控制服务, 质量保证服务, 监管服务, 包装
地区: 欧洲
批量大小: 大的, 中等的
类别/产品: 化学合成, 粒子工程

服务: 后勤, 开发服务, 制造服务, 分析/质量控制服务, 质量保证服务, 监管服务, 包装
地区: 亚太地区
批量大小: 大的, 小的, 中等的
类别/产品: 化妆品, 化学合成, 服务, 粒子工程
服务: 后勤, 开发服务, 分析/质量控制服务, 质量保证服务, 包装
地区: 亚太地区
类别/产品: 化学合成, 粒子工程
批量大小: 小的

市场: EMA (EU), ANVISA (Brazil), ISP (Chile), DIGEMID (Peru), 俄罗斯卫生当局, MHRA (UK), INVIMA (Colombia), SFDA (Saudi Arabia), TGA (Australia)
地区: 亚太地区, MENA, 拉丁美洲, 欧洲, 北美
遵守: DIGEMID, ANVISA (Brazil B-GMP), Roszdravnadzor (Russia GMP), ECOVADIS, TGA (Australia GMP), UAE Ministry of Health & Prevention, SFDA (Saudi Food & Drug Authority), INVIMA, ISP (Chile BPM), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP)
批量大小: 大的, 中等的
使用: 人类, 兽医
BSL(生物安全等级): 1
服务: 开发服务, 制造服务, 分析/质量控制服务, 质量保证服务, 监管服务, 包装
专业治疗领域 (ATC): (J) 全身使用的抗感染药
受控物质: 滥用可能性最低
OEB(职业暴露带): 2(PDE = 1,000 - 10,000 微克/天), 1 / 低危害(PDE > 10,000 µg/天)
类别/产品: FDF / 药品
市场: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), ANMAT (Argentina), MFDS (South Korea), TGA (Australia)
服务: 后勤, 开发服务, 制造服务, 分析/质量控制服务, 质量保证服务, 监管服务, 包装
地区: 欧洲
遵守: FDA (cGMP), ISO, ANVISA (Brazil B-GMP), ECOVADIS, TGA (Australia GMP), INVIMA, ISP (Chile BPM), ANMAT (Argentina nueva GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)
批量大小: 大的, 小的, 中等的
使用: 人类, 兽医
专业治疗领域 (ATC): (三) 心血管系统, (M) 肌肉骨骼系统, (N) 神经系统, (A) 消化道和新陈代谢
受控物质: 滥用可能性最低, 滥用可能性低, 降低滥用的可能性
OEB(职业暴露带): 2(PDE = 1,000 - 10,000 微克/天), 3(PDE = 100 - 1,000 微克/天), 1 / 低危害(PDE > 10,000 µg/天)
类别/产品: FDF / 药品
OEB(职业暴露带): 5 / HPAPI(PDE < 10 微克/天), 4 / HPAPI(PDE = 10 - 100 微克/天), 2(PDE = 1,000 - 10,000 微克/天), 3(PDE = 100 - 1,000 微克/天), 1 / 低危害(PDE > 10,000 µg/天)
市场: EMA (EU)
地区: 欧洲
使用: 人类
BSL(生物安全等级): 1, 2
服务: 制造服务, 包装
批量大小: 小的, 中等的
遵守: EMA (EU GMP)
类别/产品: 生物制剂, FDF / 药品
BSL(生物安全等级): 3, 1, 2
市场: EMA (EU), PMDA (Japan), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MHRA (UK), INVIMA (Colombia), MFDS (South Korea), TGA (Australia)
地区: 欧洲
批量大小: 大的, 中等的
使用: 人类, 兽医
服务: 开发服务, 制造服务, 分析/质量控制服务, 质量保证服务, 监管服务, 包装
专业治疗领域 (ATC): (三) 心血管系统, (D) 皮肤科, (J) 全身使用的抗感染药, (N) 神经系统, (R) 呼吸系统, (A) 消化道和新陈代谢
受控物质: 滥用可能性最低, 滥用可能性低, 降低滥用的可能性
遵守: PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), ECOVADIS, INVIMA, ISP (Chile BPM), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)
OEB(职业暴露带): 2(PDE = 1,000 - 10,000 微克/天), 3(PDE = 100 - 1,000 微克/天), 1 / 低危害(PDE > 10,000 µg/天)
类别/产品: FDF / 药品
遵守: ICH, FDA (cGMP), ISO, EMA (EU GMP), World Health Organization (GMP / HACCP)
市场: EMA (EU), FDA (USA)
地区: 欧洲
批量大小: 大的, 小的, 中等的
使用: 人类, 兽医
类别/产品: 寡核苷酸
服务: 开发服务, 制造服务, 分析/质量控制服务, 质量保证服务, 监管服务
OEB(职业暴露带): 4 / HPAPI(PDE = 10 - 100 微克/天), 2(PDE = 1,000 - 10,000 微克/天), 3(PDE = 100 - 1,000 微克/天), 1 / 低危害(PDE > 10,000 µg/天)
市场: EMA (EU), FDA (USA), MHRA (UK)
地区: 欧洲
遵守: FDA (cGMP), French Service-Public (CIR), EMA (EU GMP), MHRA (UK GMP)
批量大小: 大的, 小的, 中等的
使用: 人类
BSL(生物安全等级): 1, 2
服务: 开发服务, 制造服务, 分析/质量控制服务, 质量保证服务, 监管服务, 包装
类别/产品: 生物制剂
Are you a pharmaceutical company seeking a reliable CMO or CDMO partner to accelerate your drug development process? Look no further than MAI CDMO Network. Our advanced search platform connects you with a vast network of qualified contract manufacturers and development organizations worldwide.
Why Choose MAI CDMO Network?
- Comprehensive Provider Directory: Discover a diverse range of CMOs and CDMOs specializing in various services, including API manufacturing, clinical trial supplies, fill-finish, packaging, and more.
- Tailored Search Capabilities: Our advanced search filters allow you to refine your search based on specific criteria such as location, capabilities, capacity, and regulatory compliance.
- Global Reach: Connect with CMOs and CDMOs from around the world to find the perfect partner for your global projects.
- Time and Cost Savings: Streamline your sourcing process and reduce time-to-market by finding the right partner on our platform.
- Enhanced Decision Making: Access detailed company profiles, case studies, and reviews to make informed decisions.
How MAI CDMO Network Works
- Create a Free Account: Sign up for a free account to access our extensive database of CMOs and CDMOs.
- Refine Your Search: Use our advanced search filters to identify providers that meet your exact requirements.
- Request Quotes: Contact selected providers directly to request quotes and learn more about their services.
- Make Informed Decisions: Compare quotes, review company profiles, and select the best partner for your project.
Key Benefits of Partnering with a CMO/CDMO
- Accelerated Time-to-Market: Leverage the expertise and resources of a CMO/CDMO to expedite your drug development process.
- Reduced Costs: Benefit from economies of scale and specialized equipment to reduce manufacturing costs.
- Improved Quality: Ensure product quality and compliance with regulatory standards through rigorous quality management systems.
- Increased Flexibility: Scale up or down production as needed to meet changing market demands.
- Focus on Core Competencies: Outsource non-core activities to free up internal resources for innovation and strategic initiatives.
Featured Services
- API Manufacturing: Source high-quality active pharmaceutical ingredients from experienced manufacturers.
- Clinical Trial Supplies: Secure reliable and compliant supplies for your clinical trials.
- Fill-Finish and Packaging: Partner with experts in sterile filling, lyophilization, and packaging to ensure product stability and patient safety.
- Analytical Testing: Access a wide range of analytical services to support your drug development program.
Ready to Find Your Ideal CMO/CDMO Partner? Register Now
Explore our platform today and discover how MAI CDMO Network can help you achieve your drug development goals.







